Japan Pen Needle Market Size, Share, By Product Type (Standard Pen Needle and Safety Pen Needle), By Therapy (Insulin, Glucagon-like-peptide-1, and Growth Hormone), Japan Pen Needle Insights, Industry Trend, Forecasts to 2035

Japan Pen Needle Insights Forecasts to 2035

• Japan Pen Needle Market Size 2024: USD 198.4 million
• Japan Pen Needle Market Size 2035:  USD 434.6 million
• Japan Pen Needle Market CAGR 2024: 12.9%
• Japan Pen Needle Market Segments: Product Type and Therapy

The Japan pen Needle market refers to the industry producing disposable needles used with insulin and other drug delivery pens for diabetes and hormone therapies, which guarantee safe, precise and easy-to-use injections.

Terumo developed the Nanopass 34G pen needle, which stands as one of the thinnest needles in the world, through its design that features a double-tapered structure and an asymmetric bevel to decrease injection pain while enhancing patient comfort.

The Japan pen Needle market shows positive growth because rising diabetes rates combine with an increasing elderly population and more people requiring home self-injection treatments, and the growing need for ultra-thin, painless, smart pen needle technologies.

Market Dynamics of the Japan Pen Needle Market:

The Japan pen needle market is driven by the rising prevalence of diabetes, the growing elderly population, and the increasing adoption of insulin pen therapy for convenient drug delivery. Additionally, advancements in ultra-thin and painless needle technologies, along with strong healthcare infrastructure and patient awareness about effective diabetes management, are further boosting demand for pen needles across hospitals, clinics, and home care settings.

The Japan pen needle market is restrained by the high cost of advanced pen Needle and strict regulatory approvals for medical devices. Additionally, growing adoption of alternative diabetes treatments such as insulin pumps may limit market growth

.

The future of the Japan pen needle market is bright and promising, with increasing demand for home-based diabetes care, technological advancements in painless needles, and rising use of injectable therapies for chronic diseases.

Market Segmentation

The Japan pen needle market share is classified into product type and therapy.

By Product Type:

The Japan pen needle market is divided by product type into standard pen needle and safety pen Needle. Among these, the standard pen needle segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Due to their wide availability, lower cost, ease of use, and strong adoption among diabetic patients for daily insulin administration.

 By Therapy:

The Japan pen needle market is divided by therapy into insulin, glucagon like peptide and growth hormone. Among these, the insulin segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Due to the high prevalence of diabetes in Japan, the widespread use of insulin pens for effective and convenient blood glucose management.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Japan pen needle market, along with a comparative evaluation primarily based on their Category offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes Category development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in Japan Pen Needle Market:

• Termo 
• Nipro 
• Arkray
• Embecta
• Novo 
• BD
• Ypsomed 
• B. Braun SE
• Others

Key Target Audience

• Market Players
• Investors
• End Users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan pen needle market based on the below-mentioned segments:

Japan Pen Needle Market, By Product Type

• Standard Pen Needle
• Safety Pen Needle

Japan Pen Needle Market, By Therapy

• Insulin
• Glucagon-like-peptide-1
• Growth Hormone